Debt-to-equity of Ensysce Biosciences, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Ensysce Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
Ensysce Biosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 79%, a 4.6% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Ensysce Biosciences, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	79%	+3%	+4.6%	30 Sep 2025
Q2 2025	55%	-70%	-56%	30 Jun 2025
Q1 2025	53%	-54%	-50%	31 Mar 2025
Q4 2024	49%	-172%	-78%	31 Dec 2024
Q3 2024	75%	-830%	-92%	30 Sep 2024
Q2 2024	125%	+691%		30 Jun 2024
Q1 2024	107%	+476%		31 Mar 2024
Q4 2023	221%	+722%		31 Dec 2023
Q3 2023	905%	+1358%		30 Sep 2023
Q2 2023	-566%	+206%	+27%	30 Jun 2023
Q1 2023	-369%	+3858%	+91%	31 Mar 2023
Q4 2022	-501%	+6831%	+93%	31 Dec 2022
Q3 2022	-454%	-4704%	-111%	30 Sep 2022
Q2 2022	-772%	-2197%	-154%	30 Jun 2022
Q1 2022	-4227%	-3424%	-426%	31 Mar 2022
Q4 2021	-7332%	-4368%	-147%	31 Dec 2021
Q3 2021	4250%	+3021%	+246%	30 Sep 2021
Q2 2021	1425%	+542%	+61%	30 Jun 2021
Q1 2021	-803%	-1322%	-255%	31 Mar 2021
Q4 2020	-2964%	-3250%	-1138%	31 Dec 2020
Q3 2020	1229%	+965%	+366%	30 Sep 2020
Q2 2020	883%	+614%	+228%	30 Jun 2020
Q1 2020	520%	+253%	+95%	31 Mar 2020
Q4 2019	286%	+20%	+7.6%	31 Dec 2019
Q3 2019	264%	0%	+0.08%	30 Sep 2019
Q2 2019	269%			30 Jun 2019
Q1 2019	267%			31 Mar 2019
Q4 2018	265%			31 Dec 2018
Q3 2018	264%			30 Sep 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.